Aytu BioPharma, Inc. (LON:0A8M)

Aytu BioPharma Revenue

In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M USD with 1.84% growth. Aytu BioPharma had revenue of $15.14M in the quarter ending June 30, 2025, with 3.71% growth.

• Revenue: $66.38M
• Revenue Growth: +1.84%
• P/S Ratio: 0.34
• Revenue / Employee: $799.78K
• Employees: 83
• Market Cap: 16.49M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	66.38M	1.20M	1.84%
Jun 30, 2024	65.18M	-8.62M	-11.67%
Jun 30, 2023	73.80M	-22.87M	-23.66%
Jun 30, 2022	96.67M	31.04M	47.29%
Jun 30, 2021	65.63M	38.00M	137.52%